Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

425 ARTÍCULOS , VIENDO DEL 46 AL 60

Benzimidazole-derived Compounds Designed for Different Targets of Alzheimer's Disease

Gulcan HO, Mavideniz A, Sahin MF, Orhan IE.

Curr Med Chem. 2019;26(18):3260-3278. doi: 10.2174/0929867326666190124123208.

Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases

Tcw J.

Neurosci Lett. 2019 Apr 23;699:31-40. doi: 10.1016/j.neulet.2019.01.043. Epub 2019 Jan 24.

Derivatives and Analogues of Resveratrol: Recent Advances in Structural Modification

Li QS, Li Y, Deora GS, Ruan BF.

Mini Rev Med Chem. 2019;19(10):809-825. doi: 10.2174/1389557519666190128093840.

Nutrients in Alzheimer's Disease: The Interaction of Diet, Drugs and Disease

Liyanage SI, Vilekar P, Weaver DF.

Can J Neurol Sci. 2019 Jan;46(1):23-34. doi: 10.1017/cjn.2018.353.

Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options

Cummings JL, Tong G, Ballard C.

J Alzheimers Dis. 2019;67(3):779-794. doi: 10.3233/JAD-180766.

The P2X7 receptor: a new therapeutic target in Alzheimer's disease

Illes P, Rubini P, Huang L, Tang Y.

Expert Opin Ther Targets. 2019 Mar;23(3):165-176. doi: 10.1080/14728222.2019.1575811.

Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer's disease

Tiozzo Fasiolo L, Manniello MD, Bortolotti F, Buttini F, Rossi A, Sonvico F, Colombo P, Valsami G, Colombo G, Russo P.

J Drug Target. 2019 Nov;27(9):984-994. doi: 10.1080/1061186X.2019.1574300. Epub 2019 Feb 11.

Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?

Dong Y, Li X, Cheng J, Hou L.

Int J Mol Sci. 2019 Jan 28;20(3):558. doi: 10.3390/ijms20030558.

Target Enzyme in Alzheimer's Disease: Acetylcholinesterase Inhibitors

Saxena M, Dubey R.

Curr Top Med Chem. 2019;19(4):264-275. doi: 10.2174/1568026619666190128125912.

Facts, Results, and Perspectives of the Current Alzheimer's Disease Research

Marco-Contelles J.

ACS Chem Neurosci. 2019 Mar 20;10(3):1127-1128. doi: 10.1021/acschemneuro.9b00034. Epub 2019 Feb 1.

New evolutions in the BACE1 inhibitor field from 2014 to 2018

Hsiao CC, Rombouts F, Gijsen HJM.

Bioorg Med Chem Lett. 2019 Mar 15;29(6):761-777. doi: 10.1016/j.bmcl.2018.12.049. Epub 2019 Jan 4.

Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy

Nalivaeva NN, Turner AJ.

Br J Pharmacol. 2019 Sep;176(18):3447-3463. doi: 10.1111/bph.14593. Epub 2019 Mar 11.

Autophagy in Alzheimer's disease and promising modulatory effects of herbal medicine

Zeng Q, Siu W, Li L, Jin Y, Liang S, Cao M, Ma M, Wu Z.

Exp Gerontol. 2019 May;119:100-110. doi: 10.1016/j.exger.2019.01.027. Epub 2019 Jan 30.

Small Molecule Natural Products and Alzheimer's Disease

Wu X, Cai H, Pan L, Cui G, Qin F, Li Y, Cai Z.

Curr Top Med Chem. 2019;19(3):187-204. doi: 10.2174/1568026619666190201153257.

Important advances in Alzheimer's disease from the use of induced pluripotent stem cells

Majolo F, Marinowic DR, Machado DC, Da Costa JC.

J Biomed Sci. 2019 Feb 6;26(1):15. doi: 10.1186/s12929-019-0501-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias